Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-02 22:00:16 - browse：81

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： CDC wastewater surveillance dashboard to track bird flu hotspots

entertainment

WSS

Readout LOUD podcast: What to know about H5N1 bird flu

CDC wastewater surveillance dashboard to track bird flu hotspots

H5N1 bird flu: what we're starting to learn about infection in cows

CDC wastewater surveillance dashboard to track bird flu hotspots

H5N1 communication has been strictly for the birds

Telehealth for opioid use disorder is lifesaving

hotspot

Wikipedia

leisure time

Moonlake's readout produced a cash windfall. Risks remain

Generate Biomedicines machine learning biotech raises $273M

Sports medicine is finally prioritizing gender equality

Food makers to regulators: Ultra

Supreme Court strikes down use of affirmative action

CDC wastewater surveillance dashboard to track bird flu hotspots

In age of alternative facts, a scholarly course on calling out crap

IRA could hurt research into orphan drugs for rare diseases

Continuity nursing helped my family in our darkest PICU moments

Medicare says breakthrough device reimbursement rule to come by summer

explore

Generate Biomedicines machine learning biotech raises $273M

First recipient of genetically engineered pig kidney has died

Telehealth startups turn to complex chronic diseases

Steward Health Care files for bankruptcy

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Food makers to regulators: Ultra

focus

entertainment

explore

entertainment